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KAJIAN SITOTOKSIK SECARA IN VITRO DAN INDUKSI APOPTOSIS 
OLEH EKSTRAK METANOL BUAH Calophyllum inophyllum TERHADAP 
TITISAN SEL PAYUDARA MANUSIA MCF-7 
 
ABSTRAK 
Calophyllum inophyllum adalah sejenis tumbuhan bakawali yang kaya 
dengan nilai-nilai perubatan yang telah dimanfaatkan secara meluas dari zaman 
dahulu lagi untuk menyembuhkan pelbagai penyakit. Walaupun C. inophyllum 
termahsyur dengan sejarah perubatan tradisionalnya, tetapi hanya sedikit bukti 
saintifik yang melaporkan tentang ketoksikan C. inophyllum khususnya buah C. 
inophylum, dimana tiada kajian langsung yang melaporkan tentang mekanisma tahap 
molekul yang komprehensif. Oleh itu, penyelidikan ini telah dilaksanakan untuk 
menentukan ketoksikan ekstrak buah C. inophyllum secara in vitro terhadap titisan 
sel kanser manusia MCF-7 dengan penjelasan terperinci mengenai mekanisma tahap 
molekular disebalik kematian sel kanser. Dalam kajian ini, pengesahan spesies 
tumbuhan serta analisis jumlah kandungan fenol telah dijalankan. Kesan sitotoksisiti 
ekstrak buah C. inophyllum terhadap titisan sel kanser MCF-7 telah dinilai dengan 
menjalankan ujian-ujian MTT dan CyQuant yang menunjukkan perencatan 
pertumbuhan sel MCF-7 dengan nilai IC50 sebanyak 19.63 µg/mL dan 27.54 µg/mL 
masing-masing. Penelitian terhadap morfologi sel MCF-7 setelah dirawat dengan 
ekstrak buah C. inophyllum pada kepekatan IC50 (23.59 µg/mL) telah memaparkan 
ciri-ciri histologi apoptosis yang jelas. Analisis Sitometri-Aliran dengan pewarnaan 
Annesin V/ Propidium Iodida ke atas sel MCF-7 yang dirawat dengan ekstrak buah 
C. inophyllum telah menunjukkan penginduksian apoptosis yang bergantung kepada 
dos kepekatan ekstrak. Selain itu, analisis Sitometri-Aliran tentang kitaran sel 
 xx 
 
menunjukkan bahawa rawatan ekstrak buah C. inophyllum mengakibatkan rencatan 
kitaran sel MCF-7 di fasa G0/G1 dan G2/M. Aktiviti spesies oksigen reaktif (ROS) 
telah dikaji dan didapati pengasilan ROS lebih tinggi dalam sel-sel MCF-7 yang 
telah dirawat dengan kepekatan IC50 (23.59 µg/mL) eksrak buah C. inophyllum 
berbanding sel-sel yang tidak dirawat. Tambahan pula, ekstrak buah C. inophyllum 
didapati menyebabkan hilangnya potensial membran mitokondria (∆ѱm) dalam sel-
sel MCF-7 yang bersandarkan kepekatan ekstrak. Aktiviti enzim caspase-3 dalam sel  
MCF-7 yang dirawat dengan nilai kepekatan IC50 (23.59 μg/mL) ekstrak buah C. 
inophyllum telah mendedahkan hidrolisis substrat yang tinggi berbanding dengan sel-
sel yang tidak dirawat. Data ini menunjukkan bahawa ekstrak menginduksi apoptosis 
melalui pengaktifan caspase-3. Di samping itu, ujian comet menunjukkan 
fragmentasi DNA genomik berlaku bersandarkan kepekatan ekstrak yang telah 
dinilai melalui penilaian panjang ekor, moment ekor dan % kandungan DNA dalam 
ekor secara kolektif. Kesimpulannya, berdasarkan data yang diperolehi daripada 
keseluruhan kajian ini menunjukkan ketoksikan buah C. inophyllum secara in vitro 
dan juga penjelasan menyeluruh tentang mekanisma tahap molekul berkenaan 
kematian sel yang jelas diaruhkan melalui laluan ‘apoptosis-dalaman’ yang 
bergantung pada caspase. Memandangkan apoptosis sebagai pendekatan klinikal 
yang diterima untuk mengaruhkan kematian sel kanser, ekstrak buah C. inophyllum 
boleh menjadi sumber drug antikanser yang baru.  
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IN VITRO INVESTIGATION OF CYTOTOXICITY AND APOPTOSIS 
INDUCTION BY METHANOL EXTRACT OF Calophyllum inophyllum 
FRUIT IN MCF-7 HUMAN BREAST CANCER CELL LINE 
 
ABSTRACT 
Calophyllum inophyllum is an exquisite plant species with rich 
ethnomedicinal values have been diversely utilized to heal several diseases. In spite 
of its long-established sophisticated traditional medicinal properties, only a few 
investigations have reported its cytotoxicity especially fruit extract, with absolutely 
no means of scientific evidence of its comprehensive molecular mechanism. Hence, 
this study was conducted to determine the in vitro cytotoxicity of C. inophyllum fruit 
extract against MCF-7 human breast cancer cells with an intricate elucidation of the 
molecular mechanism of the cell death. In this study, authentication of the plant 
species and the determination of total phenolic content were carried out. The 
cytotoxic effect of C. inophyllum fruit extract against MCF-7 cancer cells was 
evaluated through MTT and CyQuant assays which demonstrated the inhibition of 
cell viability with the IC50 values 19.63 µg/mL and 27.54 µg/mL respectively.  The 
preliminary time-based morphological investigation of MCF-7 cells treated with the 
IC50 value (23.59 µg/mL) of C. inophyllum fruit extract revealed prominent 
histological characteristics of apoptosis. Flow cytometric analysis of Annexin V/ 
Propidium Iodide assay ascertained the induction of apoptosis in C. inophyllum-
treated MCF-7 cells in a dose-dependent manner. Moreover, flow cytometric cell 
cycle analysis demonstrated cell cycle arrest at G0/G1 and G2/M phases 
simultaneously. Reactive oxygen species (ROS) activity revealed that C. inophyllum 
fruit extract induces the generation of ROS in treated MCF-7 cells when compared to 
 xxii 
 
the untreated cells. Furthermore, C. inophyllum fruit extract dose-dependently 
decreases the mitochondrial membrane potential (∆ѱm) in MCF-7 cells. The 
enzymatic activity of caspase-3 in MCF-7 cells treated with the IC50 value (23.59 
µg/mL) of C. inophyllum fruit extract in comparison with untreated cells revealed an 
elevated hydrolysis of the substrate in treated cells, upholding that the extract 
induced apoptosis via activation of caspase-3. In addition, comet assay showed a 
dose-dependent genomic DNA fragmentation indicated by the evaluation of tail 
length, tail moment and tail DNA collectively. Conclusively, based on the data 
obtained from this overall study not only determined the in vitro cytotoxicity of C. 
inophyllum fruit extract but also shed light on its comprehensive molecular 
mechanism which clearly indicated a caspase-dependent intrinsic apoptotic pathway 
of cell death. Considering apoptosis as a clinically admissible approach of cancer cell 
death, C. inophyllum fruit extract could be a promising novel anticancer drug 
candidate.
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CHAPTER 1: INTRODUCTION 
1.1 Overview and Rationale of Study 
Cancer which is also known as malignancy or malignant neoplasm can be 
characterized by the abnormal or uncontrolled growth of cells with the potential to 
invade to other parts of the body. According to the International Agency for 
Research on Cancer GLOBOCAN database and the World Health Organization 
(WHO), cancer is one of the leading causes of morbidity and mortality rate globally 
with approximately 8.2 million cancer-related deaths and 14.1 million new cases of 
cancer in 2012 (Ferlay et al., 2015). There are more than 100 types of cancer which 
include breast cancer, lung cancer, prostate cancer, colon cancer, stomach cancer and 
liver cancer. Among all types of cancer, breast cancer is the most commonly 
diagnosed invasive cancer among women in the United States of America (USA) and 
is one of the leading causes of death due to cancer (Sun and Liu, 2006). An 
estimation of 234,190 new cases of invasive breast cancer and 40,730 breast cancer 
deaths are expected to occur among the population of the USA in 2015 (American 
Cancer Society, 2015; Siegel et al., 2015). In fact, according to National Cancer 
Registry, Ministry of Health, Malaysia (2011) breast cancer is the leading cause of 
death in Malaysia.   
There are several types of breast cancer including the ductal carcinoma, 
lobular carcinoma and the rarely reported inflammatory breast cancer, Phyllodes 
tumor, angiosarcoma and Paget disease of nipples. Therefore, breast cancer is 
extremely difficult to treat due to several distinct classes of tumors that exhibit 
different treatment responses (Sun and Liu, 2006). Numerous drugs have been 
discovered for the treatment of breast cancer such as trastuzumab (Herceptin), 
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lapatinib (Tykerb), bevacizumab (Avastin), doxorubicin (Adriamycin), docetaxel 
(Taxotere), fluorouracil (Adrucil), paclitaxel (Taxol), methotrexate (Trexall), 
cyclophosphamide (Cytoxan) and tamoxifen (Hamilton, 2014; Hirsch, 2014; Mates 
et al., 2015). However, each of the chemotherapeutic drugs has its own limitations as 
well as side effects and in the case of non-steroidal anti-estrogen medicine, 
tamoxifen, it has been reported to be effective in only one-third of the breast cancer 
patients. In addition, resistance to artificial anticancer drugs is also a foremost 
problem to be taken into consideration in the treatment of this disease. Thus, 
searching for new alternative agents for the prevention and treatment of breast cancer 
is in great need of producing better novel drugs. 
It has been reported that over 60% of the novel drugs discovered for the 
treatment of cancer were originated from natural products such as plants, marine 
organisms and microorganisms (Newman et al., 2003; Val’ko et al., 2007). There is 
a significant biological and ecological foundation behind the production of new 
bioactive secondary metabolites with potent anticancer properties which also have a 
lengthy history in sophisticated traditional medicine systems (Khazir et al., 2014). 
Our earth is rich in plant species in which only a fraction of the plants have been 
scientifically studied and reported to have chemical and pharmacological properties 
such as the antitumor activity due to the presence of a diverse range of anticancer 
compounds such as flavonoids, alkaloids, terpenoids, phenylpropanoids (Talib and 
Mahasneh, 2010). Fruits, vegetables, and spices are also known to be important 
therapeutic candidates which have been widely used in traditional medication since 
ancient times and believed to suppress cancer due to the presence of numerous 
anticancer components such as curcumin, genistein, resveratrol, isoflavones, 
saponins, beta-carotene, phytosterols, indole-3-carbinol, folic acids, selenium, and 
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flavonoids (Bhanot et al., 2011). Thus, it is necessary to explore and study the 
medicinal values of plant species for the discovery of novel anticancer agents as an 
alternative treatment for cancers. 
The combination of knowledge of botanical, phytochemical, biological, and 
molecular techniques have lead to the discovery and development of anticancer drugs 
from plant extracts where the process begins with the identification of plant species 
with medicinal properties followed by the isolation and characterization of the 
bioactive compounds that is responsible for the biological activity through an 
appropriate bioassay fractionation (Balunas and Kinghorn, 2005). The recent 
developments in technology in the drug discovery field through experimental and 
computational approaches have expanded the range of research area. Discovery of 
anticancer drugs from plant extracts generally employ the cell-based screening of the 
drug for anti-proliferative effects through cytotoxicity assays followed by the 
determination of the mechanisms of action of the prospective anticancer agent in 
selective cancer cell lines by utilization of several bioassays. 
Therefore, this study would contribute to the development of anticancer 
agents from the natural product of local medicinal plant namely Calophyllum 
inophyllum. C. inophyllum is commonly known as Alexandrian Laurel, Tamanu, 
Pannay Tree and Sweet Scented Calophyllum in English (Dweck and Meadows, 
2002). Local Malay names of this C. inophyllum include bintagor, penaga or kamani 
(Friday and Okano, 2006). C. inophyllum is a well known ornamental plant species 
with a long history of medicinal value in which its leaves, barks, flowers, fruits and 
seeds are widely used in traditional practices. A study conducted by Yimdjo et al. 
(2004) on the chemical constituents of the root bark and nut of C. inophyllum, 
reported that this specific species contains antimicrobial and cytotoxic compounds 
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especially xanthone derivatives which are claimed to be the leading compounds in 
anticancer drugs (Goh and Jantan, 1991). Besides xanthone, previous scientific 
studies have also identified compounds such as biflavonoids, benzophenones, 
neoflavanoids, and coumarin derivatives in C. inophyllum and these are reported to 
have anticancer, antitumor and lipid peroxidation properties (Kathiresan et al., 2006). 
Moreover, all parts of this plant have been employed as antiseptics, astringents, 
expectorants, diuretics, purgatives, which emphasize the high medicinal properties of 
this plant (Ali et al., 1999). A scientific study conducted by Narayan and his 
colleagues (2011) revealed that the extract of C. inophyllum bark inhibited HIV-1 
protease (HIV-PR) and HIV-1 integrase (HIV-IN) enzymes, which provides the 
scientific evidence for AIDS treatment. However, the pharmacological activity of C. 
inophyllum fruit extract is least investigated and reported. Hence, further studies on 
the methanol extract of C. inophyllum fruits are required to have a better 
understanding of their cytotoxicity mechanisms in breast cancer cells. The present 
study has been conducted with the incorporation of cytotoxicity assays such as MTT 
and CyQuant assays. Preliminary studies on the morphology of cells have also been 
deliberated through Giemsa staining with the IC50 value evaluated through the former 
assays and demonstrated the morphological criteria of apoptosis. In addition, several 
bioassays were also performed to study its mechanisms of action which includes 
Annexin V-FITC/PI assay, cell cycle assay, reactive oxygen species (ROS) assay, 
mitochondrial membrane potential analysis, comet assay and caspase 3 assay.  
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1.2 Objectives 
The current study of undertaken with the objective: 
1) To study the cytotoxic activitiy of C. inophyllum fruit extract against MCF-7 
breast cancer cells.  
2) To investigate the possible anticancer mechanism of action of C. inophyllum 
fruit extract against MCF-7 breast cancer cells. 
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CHAPTER 2.0: LITERATURE REVIEW 
2.1 Cancer 
Genetically programmed cell division and differentiation occur in the process of 
formation of specific tissues and eventually functional organs. However, 
intermittently the above events may give rise to tissue masses called tumors, or 
neoplasms. A single mass of benign tumor is usually not life threatening since it can 
be cured completely by surgical removal. However, when the cells of a tumor start to 
invade and interrupt the surrounding tissues, the tumor is said to be malignant and is 
identified as cancer which can consequently lead to death due to injury to vital 
organs, secondary infection, metabolic problems, secondary malignancies, or 
hemorrhage (Russell, 2010). The place where cancer begins is known as the original 
or primary site. A malignant tumor can break away from its original location and 
invade far-away sites through the lymphatic system, forming new tumors. This 
process is known as metastasis. The uncontrollable growth of cells may occur in any 
parts of the body leading to more than 100 types of cancer including lung cancer, 
breast cancer, cervical cancer, stomach cancer, prostate cancer, bowel cancer and 
ovarian cancer.  
 According to the American Cancer Society (2015), risk factors for cancer 
include genetic factors as well as the lifestyle of a person such as tobacco use, 
alcohol use, diet, and physical activity. Other disposing factors to cancer are certain 
type of infections such as human papilloma virus (HPV), Epstein-Barr virus (EBV), 
hepatitis B, hepatitis C and Helicobacter pylori. Environmental exposures to diverse 
range of chemicals, radiations and even overexposure to ultraviolet (UV) light from 
the sun may also lead to cancer. Smoking and alcohol intake can be associated with 
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several cancers such as the mouth, oral cavity, pharynx, larynx, esophagus, lung, 
stomach, pancreas and even colon (Schmidt and Popham, 1981). Besides, viral 
infection can be related to cancer because of their capability to integrate into the 
DNA of the human stem cell where it mutates and transforms the cell to be the parent 
of the malignant clone (Doll and Peto, 1981). 
 The severity of the disease depends on the degree of primary tumor and its 
competence of invading to other parts of the body. Therefore, the stage of the cancer 
is identified prior to proceed with any sort of treatments. Generally, there are four 
stages of cancer as described in Table 2.1.  
There are several types of treatments available for cancer including surgery, 
radiation therapy, chemotherapy, immunotherapy, hyperthermia, and stem cell 
transplant. However, these treatments have excruciating side effects that vary from 
person to person depending on the frequency of treatment, the age of the person and 
other health conditions. Commonly occurring side effects generated by cancer 
treatments include anemia, alopecia (hair loss), constipation, edema, fatigue, memory 
problems, peripheral neuropathy, nausea and vomiting (Nordqvist, 2014; National 
Cancer Institute, 2015). Chemotherapy is one of the popular cancer treatments from 
the 1960s as the degree of curing cancer elevated at approximately 33% through 
radical local treatments. Eventually Cancer Chemotherapy National Service Centre 
was established in the effort of developing methods to screen chemicals using 
transplantable tumors in rodents (Devita and Chu, 2008). 
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Table 2.1: Stages of cancer  
STAGE DEFINITION 
Stage 0: In-situ Cancer is located in place and have not spread to 
nearby tissues which carry little or no threat to life 
with a high probability of curing 
Stage I: Localized cancer Cancer cell grows and obtain its competency to pass 
through basement membrane where it begins to 
spread to nearby tissues 
Stage II & III: Regional 
spread 
Tumor grows larger in size and its daughter cells 
spreads through lymph vessel to adjacent tissues of 
the primary tumor 
Stage IV: Distant spread Tumor invades to other parts of the body which is 
known as the secondary or metastatic cancer 
Source: American Society of Clinical Oncology, 2015 
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2.1.1 Breast Cancer 
Breast cancer is a type of cancer that evolves in cells of the breast which can invade 
to other parts of the body. Approximately one out of ten women is affected by breast 
cancer. According to the Annual Report collaboratively presented by the American 
Cancer Society (ACS), Centers for Diseases Control and Prevention (CDC), 
Surveillance, Epidemiology, and End Results Program of National Cancer Institute 
(NCI), and North American Association of Central Cancer Registries (NAACCR), 
incidence rate for breast cancer was the highest among females for 2007 to 2011 
while the death rates caused by breast cancer is at second place after lung cancer 
(American Cancer Society, 2015).  
This heterogeneous disease can be categorised by its histological patterns 
where specific architectural and cytological patterns are identified; or by its 
molecular features when gene expression profiling is studied (Weigelt and Reis-
Filho, 2009). Among the histological types of breast cancer, the lobular and 
ductal/lobular carcinoma cases are more likely to be diagnosed with stage III/IV in 
contrast to ductal carcinoma cases, while other breast cancers such as mucinous, 
tubular and papillary tumours occur in small number (Li et al., 2005). Gene 
expression study conducted by Perou et al. (2000) further classified the breast cancer 
based on their pervasive differential gene expression patterns, and divided the breast 
cancer into the basal-like, HER2, normal breast-like, luminal, luminal A and luminal 
B. Figure 2.1 shows the anatomy of the breast.  
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Figure 2.1: Anatomy of the breast 
Source: Anatomy of Physiology of the Female Reproductive System, 2015 
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Hormonal risk factors are determinant for the development of breast cancer. 
Excessive exposure to estrogen is believed to be one of the mechanisms of 
carcinogenesis in the breast cancer and this cancer can be correlated with life style 
factors including low parity, late age at first delivery, lack of breast feeding, 
increased intake of alcohol, use of hormonal contraceptives, and incidence of obesity 
(Imyanitov and Hanson, 2004; Yager and Davidson, 2006). Besides hyperestrogenia, 
several researches confirmed that constitutional genomic instability is also associated 
with breast cancer susceptibility. Mutations in BRCA1 and BRCA2 have been 
reported to attribute to breast cancer based on an evaluation of genetic heterogeneity 
in 145 breast-ovarian cancer families (Narod et al., 1995a and 1995b). There are 
epidemiological and molecular evidences for mutations in ATM gene to be linked 
with breast cancer susceptibility (Ahmed and Rahman, 2006). Germ line mutations 
also include p53, CHEK2 polymorphism and NBS1 gene that confer elevation in 
breast cancer risk (Imyanitov et al., 2003; Imyanitov and Hanson, 2004). These 
mechanisms of carcinogenesis in breast cancer are responsible for the subsequent 
genetic instability as well as the alteration of specific genetic pathways either by 
activating the oncogenes or by inactivating the suppressor genes that lead to the 
hallmarks of cancer.  
 Commonly practiced treatments for breast cancer are surgery such as 
lumpectomy, mastectomy, and sentinel node biopsy, followed by radiation therapy, 
hormone therapy and chemotherapy. According to Early Breast Cancer Trialists’ 
Collaborative Group (EBCTCG), the earliest systemic therapy found to have a 
significant improvement in survival with prevention from recurrence is tamoxifen, an 
anti-estrogen (Fisher et al., 1998). Disparate number of drugs have been discovered 
with a promising survival perk for breast cancer patients such as the trastuzumab 
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(Herceptin) that targets and blocks the human epidermal growth factor receptor 2 
(HER2) protein (Fischer et al., 2003); anthracyclines like doxorubicin and epirubicin 
as well as the taxanes like paclitaxel and docetaxel which have been reported to be 
potential therapeutic agents for advanced breast cancer (Esteva et al., 2001).  
Therapeutic strategies utilized in the discovery of novel therapeutic agents for 
breast cancer are the properties of cancer cells, in which, genetic instability and 
uncontrollable cell growth are taken into consideration; molecular targets where 
tumor-specific anchors are targeted for the delivery of cytostatic substances; and 
finally some genuine targets which mainly focus on suppressing the molecules 
essential for breast cancer maintenance (Imyanitov and Hanson, 2004).  
 Recently, complementary and alternative medicines (CAM) have drawn an 
extra interest among oncologists and breast cancer patients, and therefore CAM has 
been generally practiced in combination with the conventional therapy. CAM have 
associated with natural herbal medicines which are believed to protect the body from 
malignancy by inhibiting the growth of cancer through various biological and 
molecular mechanisms and also by reducing the lethal side effects and complications 
caused through conventional treatments (Shahid, 2013). Therefore, discovery of 
novel anticancer cytotoxic agents from natural herbal plant parts such as roots, 
flowers, seeds, fruits, leaves or branches are exclusively anticipated for the treatment 
of breast cancer.     
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 2.2 Anticancer 
The evolution of the life threatening disease, cancer alarmed the whole world since it 
is known to be difficult to cure due to uncontrollable multiplication of abnormal cells 
leading into an invasive malignant tumor. The development of anticancer drugs 
began ever since the discovery of the anticancer properties in nitrogen mustard and 
the folic acid analogue amino protein in the 20th century that gradually led to the 
identification of clinically effective novel genotoxic drugs through cytotoxicity 
screening (Baguley, 2002).  
The evolving knowledge on cancer mechanisms has expedited the expansion 
of novel anticancer approaches. One of the most extensive conventions is to slow 
down or to inhibit the prime characteristic of cancer cells that grow uncontrollably. 
This can be correlated with the elevation of tendency of the cells to go through the 
process of cell suicide, or apoptosis. This effective route is eventually achieved 
through a mechanistic manner where the cytotoxic drugs are designed so as to 
impede the DNA replication by damaging the DNA of the cancer cells, subsequently 
inducing apoptosis. Besides cytotoxic drugs, cytosolic drugs are also used to fight 
cancer in which the drugs are designed to specifically modify the biochemical 
pathways that facilitate the fast growth of cancer cells (Denny, 1988). Although these 
drugs do not kill the cancer cells, they prevent the cancer cells from reproducing by 
exclusively interrupting their growth signalling.  
The most notable limitation and challenge encountered in the development of 
anticancer drug is the tendency of the cancer cells to achieve resistance against these 
compounds. This in turn creates a great urgency for the discovery and designing of 
anticancer drugs with improved molecular structure and mechanism of action. 
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Consequently, the abundantly available natural products including plants, 
microorganisms, and marine organisms, provide an enormous structural diversity of 
compounds for the development of novel anticancer agents (Rocha et al., 2001; 
Kinghorn et al., 2009).    
 
2.2.1. Plants as a Source of Anticancer Agents 
Beyond 60% of recognized drugs for the treatment of cancer to date are originated 
from natural products in which huge number of plant species have been proclaimed 
to possess promising anticancer effects (Rocha et al., 2001; Newman et al., 2003; 
Cragg and Newman, 2005; Val’ko et al., 2007). The breakthrough in chemical field 
such as the discovery of vinca alkaloids, vinblastine and vincristine, and the isolation 
of the cytotoxic podophyllotoxins in 1950 initiated the new aeon of exploration of 
plant sources as chemotherapeutic candidates for cancer (Cragg and Newman, 2005). 
This led to the plant collection program by the United States National Cancer 
Institute (NCI), followed by screening of plant species for anticancer activity which 
resulted in a revelation of enormous number of new anticancer agents such as 
taxanes and camptothecin (Cassady and Douros, 1980; Shoeb, 2006). 
 The natural ability of plants to produce toxins against microorganisms like 
fungi gained attention for the development of anticancer agents since recent 
evolutionary researches have demonstrated that microorganisms such as yeast and 
fungi are closely associated with mammalian cells at biochemical level (Cardenas et 
al., 1999; Hanlon and Hodges, 2013). On account of this, the chemical compounds 
produced by plants for their defence against microorganisms are postulated to have 
an inhibitory effect on human cells correspondingly. Crude extracts from plant 
samples have been established to be selectively toxic to cancer cells after passing 
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through various bioassays including in vitro and in vivo screenings which eventually 
accelerated to fractionation processes for the isolation of specific active compound 
responsible for the anticancer effect as exemplified in the discovery of approved 
drugs namely Camptothecin and Taxol. 
         The bioactive compounds of plants responsible for its anticancer properties are 
known as the secondary metabolites which are classified based on their biosynthetic 
pathways. The major groups of these secondary phytochemicals include the 
terpenoids, phenolic metabolites, alkaloids, flavonoids, polyketides and other 
nitrogen-containing metabolites (Harborne, 1999; Oksman-Caldentey and Inze, 
2004). Unlike primary metabolites such as carbohydrates, proteins and lipids, 
secondary metabolites are not involved in the growth and metabolism of plants but 
are considered as the end products of primary metabolism, that have a role as defence 
chemicals. 
 The advancement in analytical technology and biological sciences have 
allowed an impressive number of naturally occurring secondary metabolites from 
plants to be isolated and studied for their cancer chemopreventive effects. Examples 
of as such phytochemicals and derivatives which are clinically accessible include 
vinca alkaloids (vinblastine, vincristine, vinorelbine), podophyllotoxin derivatives 
(etoposide, etoposide phosphate, teniposide), taxanes (paclitaxel and docetaxel), 
campothecin derivatives (irinotecan and topotecan) and homoharringtonine (Chabner 
et al., 2005; DeVita et al., 2008; Asif, 2015; Biswas et al., 2015). These bioactive 
compounds were demonstrated to possess significant anticancer activity against lung 
cancer, breast cancer, ovarian cancer, testicular cancer, colorectral cancer, 
lymphoma, and several other cancers. This can be exemplified by etoposide that 
inhibits topoisomerase II (Liu, 1989), campothecin that inhibits topoisomerase I (Liu 
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et al., 2000), taxanes that causes mitotic arrest via stabilization of microtubules 
(Wani et al., 1971), flavopiridol that inhibits cyclin-dependent kinase (Kelland, 
2000), and homoharringtonine that inhibits protein synthesis and blocks cell-cycle 
progression (Zhou et al., 1995).        
   
2.3 Calophyllum inophyllum  
2.3.1 Botany 
C. inophyllum Linn. is commonly as Alexandrian Laurel, Laurel Wood, Tamanu, 
Pannay Tree, Sweet Scented Calophyllum, Beach Calophyllum, and Borneo 
Mahogany in English (Dweck and Meadows, 2002). It is known as Bitaog in 
Tropical Asia. Local Malay names of this species are bintagor, penaga or kamani 
(Friday and Okano, 2006).  
Synonyms of C. inophyllum includes Calophyllum bintagor Roxb., Mesua 
ferrea Linn, Balsamaria inophyllum Lour., Calophyllum apetalum Blanco 
[Illegitimate], Calophyllum blumei Wight, C. inophyllum var. blumei (Wight) Hassk., 
C. inophyllum forma oblongata Miq., C. inophyllum forma obovata Miq., C. 
inophyllum var. takamaka Fosberg, C. inophyllum var. wakamatsui (Kaneh) Fosberg 
& Sachet, Calophyllum ovatifolium Norona 
Calophyllum spurium Choisy and Calophyllum wakamatsui Kanehira (The plant 
List, 2013). 
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2.3.1. (a) Classification 
Kingdom Plantae 
Subkingdom Tracheobionta 
Phylum Trachephyta 
Class Magnoliopsida 
Subclass Dilleniidae 
Order Theales 
Family Clusiaceae-Guttiferae 
Subfamily Kielmeyeroideae 
Tribe Calophylleae 
Genus Calophyllum 
Species C. inophyllum L. 
(Stevens, 1998) 
 
2.3.1. (b) Distribution 
The native of C. inophyllum is East Africa, through southern coastal India to 
Malesia, northern Australia and the Pacific islands which further extended to 
Philipines, Taiwan and the Marianas through Southeast Asia (Dweck and Meadows, 
2002). The geographical distribution of this species also includes the coastal region 
of Polynesia and Madagscar (Friday and Okano, 2006). During the early migrations 
of Polynesian settlers, Tamanu has been introduced in Hawaii from the south Pacific 
islands (Dweck and Meadows, 2002). This species was also brought and successfully 
cultivated in southern China. The habitat of this species is mainly in the coral sands 
and on the sea shores while some samples may be established in valleys and low land 
forests (Lim, 2012).  
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2.3.1. (c) Botanical Description 
The C. inophyllum is a slow growing, medium to large sized tree reaching a height of 
about 8 to 20 m. The canopy of the tree is widely spread to an irregular crown shape. 
It has a thick, fissured and grey trunk with a rough and cracked textured bark. Its sap 
is milky white.  
Leaves of C. inophyllum are opposite with largely elliptical or oval lamina of 
10 to 20 cm long by 6 to 9 cm wide. The blunt ended leaves are strong and deep 
shiny green in colour with intimately positioned thin parallel veins organized 
perpendicularly from a prominently elevated yellowish green midrib to the rounded 
leaf boundary (Orwa et al., 2009).  
C. inophyllum bears pleasantly scented white flowers in clusters of 4 to 15 
flowers and each flower has 4 to 8 delicate oblong petals. Flowers are usually 
bisexual with a puff of golden yellowish stamens and a pink pistil with a thin, long 
style and a superior ovary.  The flowers are 2.5 cm across and 8 to 14 mm long and 
positioned on long sturdy stalks at leaf axils. The flowering is heaviest in late spring 
or early summer. 
Fruits also grow in clusters, with each fruit having a diameter of 2 to 5 cm. 
The ball shaped light green fruit has a thin compact outer layer with a smooth 
texture. When the fruit ripens, the skin turns yellow to brown and the smooth texture 
becomes wrinkled. The fruit holds a large brown seed with a diameter of 2 to 4 cm 
which contains a pale yellow kernel. The trees usually bear fruits twice a year and 
these periods are from April to June and October to December (Friday and Okano, 
2006). Figure 2.2 shows the C. inophyllum plant morphology. 
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(A) (B) 
(C) 
(D) 
Figure 2.2: C. inophyllum plant morphology  
(A) Tree with its canopy spread widely to an irregular crown;  
(B) Perpendicularly arranged leaves with blunt ends; (C) Flower clusters with 
yellow stamens; (D) Ball shaped light green fruits  
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2.3.1. (d) Propagation 
C. inophyllum is usually propagated through seeds. However, the germination of the 
seed is initially slow. Cracking the shells or shelling the seeds entirely will 
eventually germinate the seeds faster where a study established that a fully shelled 
seed germinated in 22 days, seeds in a cracked shell took 38 days to germinate, 
whereas 57 days was needed for seeds still in their shells (Elevitch and Wilkinson, 
2000; Prabakaran and Britto, 2012).  
 
2.3.2 Ethnomedicinal uses 
C. inophyllum is a well known ornamental plant species in which its leaves, barks, 
flowers, fruits and seeds are diversely used in traditional ethnomedicine. The high 
medicinal properties of all parts of this plant have also been employed as antiseptics, 
astringents, expectorants, diuretics and purgatives (Ali et al., 1999). Traditionally, its 
emetic and purgative gum extracted from the wounded bark of the plant has been 
recorded to be used for treatment of wounds and ulcers. In Asia, mainly in India and 
Indo-china, the astringent bark which contains tannins and its purgative juices are 
widely used for vaginal discharge and the passing of blood after child birth and also 
for gonorrhea (Burkill, 1994). In addition, antineuralgic, diuretic, antiseptic and 
disinfectant properties of the bark are also well known and a preparation from bark 
acts as an expectorant when taken internally which is useful in chronic bronchitis, 
and phthisis (Prabakaran and Britto, 2012). The resin is helpful in unrelieved catarrh 
while the infusion of gum, bark and leaves are used on for sore eyes. In Fiji and 
Linga, the leaves soaked in water are applied to inflamed eyes. The leaf infusion has 
been reported to be useful for the treatment of heatstroke when taken internally and it 
has also been prescribed as an inhalation for migraine and vertigo in Cambodia. In 
 21 
 
Philippines, macerated leaves are also used as astringent for haemorrhoids (piles). In 
Madagascar, Polynesia and Malaysia, bark is crushed into powder to be used for 
orchitis while the gum resin is a remedial, resolvent and antiseptic. The seed oil is 
also utilized against psoriasis and rheumatism (Prabakaran and Britto, 2012). The 
blond nut kernel in the fruits of C. inophyllum is responsible for the dark green, rich 
and pleasant smelling oil which is readily and completely absorbed when applied to 
skin, leaving no residue (Oil of Tamanu, n. d.). It is widely been used for treating 
skin diseases.  
 
2.3.3 Pharmacological Activities 
2.3.3. (a) Antiviral activity 
Fractionation of C. inophyllum extract yielded several active compounds which play 
an important role against human immunodeficiency virus type 1 (HIV-1). According 
to Patil et al. (1993), inophyllum B and P were isolated from the methanol chloride 
extract of C. inophyllum and these compounds showed strong activity against HIV-1 
by inhibiting the HIV reverse transcriptase with an IC50 value of 38 and 130 nM, 
respectively. These compounds were also reported to exhibit anti-HIV properties 
against cell culture with an IC50 value of 1.4 and 1.6 µM, respectively. Coumarin 
derivatives isolated from C. inophyllum extract such as castatolide and inophyllum P 
are potent HIV reverse transcriptase non-nucleoside inhibitors (Spino et al., 1998). 
Studies reported that inophyllums have a novel mechanism of interaction with 
reverse transcriptase and has potential to play a role in combination therapy. 
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2.3.3. (b) Anticancer activity 
Primary screening of ten 4-phenylcoumarins isolated from C. inophyllum was 
conducted by Itoigawa et al. (2001) in the search for antitumor-promoting agents and 
reported that calocaumarin-A displayed a significant inhibitory effect on Epstein-
Barr virus early antigen (EBV-EA) activation induced by 12-O-
tetradecanoylphorbol-13-acetate in Raji cells which was further confirmed by an in 
vivo two stage carcinogenesis test on mouse skin tumor promotion (Itoigawa, et al., 
2001). Although methanol extract of C. inophyllum leaves exhibited a weak 
anticancer activity against MCF-7 and HT-29 cell lines with 31.25% and 22.56% 
inhibition at 200 µg/ml tested dose, it is believed to show a higher cancer cell death 
with the identification and isolation of the potent active chemical constituent present 
in the extract (Aditya et al., 2013). 
 
2.3.3. (c) Antimicrobial activity 
Investigation conducted by Ha et al. (2009) revealed a potential antimicrobial 
activities of methanol and n-hexane extract of C. inophyllum fruit peel against 
Staphylococcus aureus, and Mycobacterium smegmatis through the disc diffusion 
method. Methanolic crude extract exhibited higher zone of inhibition in both S. 
aureus and M. smegmatis which are 58.1% and 46.9%, respectively whereas the n-
hexane crude extract demonstrated a slightly lower zone of inhibition for these 
microbes with values of 53.8% and 37.5%, respectively. Screening of ethanol and 
ethyl acetate extracts from various parts of C. inophyllum such as leaves, fruits, 
stems, flowers, and roots against Salmonella typhi, Pseudomonas aeruginosa, 
Staphylococcus aureus, Escherichia coli and Vibrio colerea have been studied 
through the cup-plate method and demonstrated promising antimicrobial properties 
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for the extracts, which can be used in the development of novel drugs for the 
treatment of contagious diseases caused by pathogens (Saravanan et al., 2011). 
Several compounds have been isolated from the fractionation of the crude extract of 
the root bark and nut of C. inophyllum which were tested against various 
microorganisms such as S. aureus, V. anguillarum, E. coli, and Candida tropicalis 
through the classic agar disc dilution method at 20 µg per disk in which compounds 
such as caloxanthone A, calophynic acid, brasiliensic acid, inophylloidic acid, 
calophyllolide, as well as inophyllum C and E demonstrated strong inhibitory 
activity against S. aureus (Yimdjo et al., 2004). The presence of phenolic compounds 
in C. inophyllum which give an acidic property is said to be responsible for the 
antimicrobial activities. Friedelin, canophyllol, canophyllic acid, and inophynone 
which are the known derivates of phenolic group in C. inophyllum demonstrated 
significant bactericidal and fungicidal action (Mahmud et al., 1998). The oil of C. 
inophyllum exhibited in vitro antibacterial activity against Gram negative bacteria. At 
20 µg per disc, the C. inophyllum extract inhibited the growth of S. aureus (Bhat et 
al., 1954). 
 
2.3.3. (d) Anti-inflammatory activity 
Anti-inflammatory effect of ethanolic extract of leaf and stem bark of C. inophyllum 
have been studied on albino Wistar rats through carrageenan induced paw edema and 
cotton pellet granuloma method which consequently demonstrated strong activities 
on both acute and chronic models of inflammation which was also directly 
proportional to the dosage of extract dosage (Baig et al., 2014). Acetone extract of C. 
inophyllum leaves displayed potential anti-inflammatory effects against 
lipopolysaccharide-induced RAW 264.7 cells which successfully suppressed the 
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nitric oxide production and also the expression of iNOS, cyclooxygenase (COX-2) 
and nuclear factor-kappa B (NF-κB) in a dosage reliant behaviour (Tsai et al., 2012). 
The anti-inflammatory activity of C. inophyllum is somewhat due to the presence of 
friedelin and triterpenes of the friedelin group, specifically canophyllal, canophyllol 
and canophyllic acid, and the heartwood xanthones such as mesuaxanthone B and 
calophyllin (Saxena et al., 1982). This inflammatory agent was found to be effective 
in both intra peritoneal and oral routes demonstrated in adrenalectomised rats 
(Gopalakrishnan et al., 1980). 
 
2.3.3. (e) Antioxidant activity 
Antioxidant properties of aqueous and methanolic extracts of C. inophyllum leaf 
have been evaluated by Dutta and Ray (2014) and demonstrated a significant free 
radical scavenging activity and reducing power for the methanolic leaf extract in a 
concentration dependent manner. The strong antioxidant activity of the methanolic 
leaf extract was related to the high phenol and flavonoid contents which are reported 
to be 140.28 ± 17.1 mg/g and 177.06 ± 5.29 mg/g, respectively (Dutta and Ray, 
2014). Several bioactive compounds have been isolated from the leaves of C. 
inophyllum and tested for antioxidant activity in hyperlipidemia model which 
revealed the compounds such as the combination of calophyllic acid and 
isocalophyllic acid, triterpene and canophyllic acid to have a strong antioxidant 
activity at the concentration of 200 µg/mL (Prasad et al., 2012). Methanolic leaf 
extract of C. inophyllum was analysed for its antioxidant activity through DPPH and 
hydrogen peroxide radical scavenging activity and reducing power activity which 
showed that the highest antioxidant activity was when the total content of an active 
compound called calocoumarin A is high (Sebastian and Britto, 2014). The oil of C. 
